Leuko Labs, Inc.
Biotechnology company · Boston, Massachusetts, United States
Leuko Labs, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2017. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $5.7 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $1.2 million sold in a notice filed in 2019.
Leuko Labs at a glance
What does Leuko Labs do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $5.7 million in total (2018 to 2024). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $1.2 million sold (2019).
Frequently asked questions about Leuko Labs
Where is Leuko Labs headquartered?
Leuko Labs, Inc. is headquartered in Boston, Massachusetts, United States.
What does Leuko Labs do?
Leuko Labs, Inc. is a biotechnology company.
When was Leuko Labs founded?
The earliest incorporation on record for Leuko Labs, Inc. is in 2017, according to public company registers.
Similar companies
- Elucid Bioimaging Inc.Boston, Massachusetts, United States
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
- Odyssey Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.